INTRODUCTION
Budd-Chiari syndrome is a rare but life-threatening disorder characterized by obstruction of the hepatic venous outflow. Treatment depends on underlying cause, extent of the obstruction and functional capacity of the liver. When all other therapy options are unsuccessful, liver transplant should be considered (1, 2, 3) .
Portal vein thrombosis (PVT) is a frequent event in patients with cirrhosis which can be treated with anticoagulants, but there are limited data regarding safety and efficacy of this approach.
CASE REPORT
We present case report of thirty five old female patient with postparthal Budd-Chiari syndrome who underwent liver transplant on 2002, and developed portal vein thrombosis in liver graft ten years later. We also evaluated safety of application of anticoagulant therapy in this patients.
In few years after liver transplantation patient developed fibrosis of liver graft with porthal hypertension. Thrombosis was diagnosed and recanalization was evaluated by using Doppler ultrasound. (Figure 1 .) We performed elective esophageal variceal band ligation in order to prevent bleeding. As soon as we prevented possible complications, anticoagulant therapy (martefarin) was administred. (Figure 2.) Complete recanalization of portal vein was achieved after four months period. Early initiation of anticoagulation was associated with complete recanalization. Our case suggested that appropriate and well prepared anticoagulant therapy in portal vein thrombosis of liver graft could pro- Anticoagulation is a relatively safe treatment that leads to partial or complete recanalization of the portal venous of patients with cirrhosis and PVT. It could be maintained for longer period to prevent rethrombosis.
